Singapore and the Philippines will conduct a serosurveillance research across ASEAN
A serosurveillance research will be conducted in the Philippines and Singapore to assess the effectiveness of vaccinations against coronavirus illness 2019 (Covid-19) throughout Asean (Association of Southeast Asian Nations).
The process of generating particular antibodies in human blood as a consequence of vaccination or infection is known as seroconversion.
“Kapag tayo ay nabakunahan o nainfect ng bacteria at virus, ang katawan ay gumagawa ng antibodies para sa susunod na ang mga ito ay makapasok sa ating katawan, mas mabilis na nya itong malabanan (When someone is inoculated or inf
Serosurveillance, she claims, is a good way to keep track on illnesses that the vaccine may prevent.
Guevara said that this is also utilized to identify which groups are at danger and to provide accurate statistics on the projected proportion of individuals who have been vaccinated.
The initiative will be supported financially by the DOST.
“The exact sum is still being worked out, but it is expected to be about USD600,000. This will be split among the Asean member nations who participate “According to the official,
According to Guevara, the research would begin in September with 200 volunteers from each Asean member state.
Meanwhile, the DOST said the research will look at various phases of vaccination as well as the duration of protection gained through vaccination.
The Research Institute for Tropical Medicine, Singapore’s Duke-NUS Medical School, and the Diagnostics Development Hub will collaborate on this, according to the DOST.